CME/CE - PACE-CME

113-128 of 173

Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
MinuteCE®
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
Alexander T. Cohen, MD, MBBS
1.00 program credit
- Alexander T. Cohen, MD, MBBS
1.00 program credit
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
CME/CE
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
Kieran McCafferty, MD; Maurizio Gallieni, MD
0.25 credits
- Kieran McCafferty, MD
- Maurizio Gallieni, MD
0.25 credits
Breaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy
Breaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy
CME/CE
Breaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy
Mikhail Kosiborod, MD; Stephen J. Greene, MD
0.25 credits
- Mikhail Kosiborod, MD
- Stephen J. Greene, MD
0.25 credits
Pulmonary Hypertension: Diagnosis, Management, and Updates – Chairperson’s Perspective
Pulmonary Hypertension: Diagnosis, Management, and Updates – Chairperson’s Perspective
CME/CE
Pulmonary Hypertension: Diagnosis, Management, and Updates – Chairperson’s Perspective
Vallerie V. McLaughlin, MD
0.25 credits
- Vallerie V. McLaughlin, MD
0.25 credits
AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care
AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care
CME/CE
AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care
Mazen Hanna, MD
- Mazen Hanna, MD
Pulmonary Hypertension Management: Practice Trends and Updates
Pulmonary Hypertension Management: Practice Trends and Updates
CME/CE Broadcast Replay
Pulmonary Hypertension Management: Practice Trends and Updates
Vallerie V. McLaughlin, MD; Victor Moles, MD
1.00 credit
- Vallerie V. McLaughlin, MD
- Victor Moles, MD
- Ioana Preston, MD
1.00 credit
Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH
Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH
CME/CE Broadcast Replay
Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH
Vallerie V. McLaughlin, MD; Thomas Cascino, MD
1.00 credit
- Vallerie V. McLaughlin, MD
- Thomas Cascino, MD
- Bradley A. Maron, MD
1.00 credit
Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates
Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates
CME/CE Broadcast Replay
Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates
Robert P. Frantz, MD, FACC; Vallerie V. McLaughlin, MD
1.00 credit
- Robert P. Frantz, MD, FACC
- Vallerie V. McLaughlin, MD
- Sonja Bartolomei, MD
1.00 credit
The Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care
The Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care
CME/CE
The Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care
Pablo Garcia-Pavia, MD, PhD; Francesco Cappelli, MD
0.50 credits
- Pablo Garcia-Pavia, MD, PhD
- Francesco Cappelli, MD
0.50 credits
ns-MRAs and eGFR Slope: The Kidney Perspective
ns-MRAs and eGFR Slope: The Kidney Perspective
MinuteCE®
ns-MRAs and eGFR Slope: The Kidney Perspective
Csaba P. Kovesdy, MD; Finnian R. McCausland, MD
1.25 program credits
- Csaba P. Kovesdy, MD
- Finnian R. McCausland, MD
1.25 program credits
ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
MinuteCE®
ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
Csaba P. Kovesdy, MD; Finnian R. McCausland, MD
1.25 program credits
- Csaba P. Kovesdy, MD
- Finnian R. McCausland, MD
1.25 program credits
FCS and SHTG: Are We Meeting the Need?
FCS and SHTG: Are We Meeting the Need?
CME/CE
FCS and SHTG: Are We Meeting the Need?
Ira J. Goldberg, MD; Kausik Ray, MBChB, MD, MPhil
0.25 credits
- Ira J. Goldberg, MD
- Kausik Ray, MBChB, MD, MPhil
- Christie Ballantyne, MD
0.25 credits
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
MinuteCE®
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
Akshay S. Desai, MD; John McMurray, OBE, BSc, MB ChB (Hons), MD, FRCP, FRSE, FMedSci, FESC, FACC, FAHA, FJCS, FHFA, FHFSA, FBSH
1.25 program credits
- Akshay S. Desai, MD
- John McMurray, OBE, BSc, MB ChB (Hons), MD, FRCP, FRSE, FMedSci, FESC, FACC, FAHA, FJCS, FHFA, FHFSA, FBSH
1.25 program credits
Mastering MRA Monitoring: The Key to Success
Mastering MRA Monitoring: The Key to Success
MinuteCE®
Mastering MRA Monitoring: The Key to Success
Akshay S. Desai, MD; John McMurray, OBE, BSc, MB ChB (Hons), MD, FRCP, FRSE, FMedSci, FESC, FACC, FAHA, FJCS, FHFA, FHFSA, FBSH
1.25 program credits
- Akshay S. Desai, MD
- John McMurray, OBE, BSc, MB ChB (Hons), MD, FRCP, FRSE, FMedSci, FESC, FACC, FAHA, FJCS, FHFA, FHFSA, FBSH
1.25 program credits
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
MinuteCE®
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
James Burton, DM, FRCP; Aaron Wong, MD
0.75 program credits
- James Burton, DM, FRCP
- Aaron Wong, MD
0.75 program credits
MinuteCE®
Strategies for managing hyperkalemia in cardiorenal disease: A clinical dialogue defining a roadmap to improved outcomes
Gianluigi Savarese, MD, PhD, FESC, FHFA; James Burton, DM, FRCP
0.75 credits 3 episodes
- Gianluigi Savarese, MD, PhD, FESC, FHFA
- James Burton, DM, FRCP
- Aaron Wong, MD
0.75 credits 3 episodes

8/9